Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators. Steg PG, et al. N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475798 Free article. Clinical Trial.
Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study.
Takeshita M, Tanaka A, Yoshida H, Nakamura I, Shibata Y, Hata S, Kushiyama A, Okutsu M, Ishizu T, Node K. Takeshita M, et al. Among authors: okutsu m. J Atheroscler Thromb. 2024 Jun 1;31(6):864-875. doi: 10.5551/jat.64574. Epub 2024 Jan 13. J Atheroscler Thromb. 2024. PMID: 38220209 Free PMC article. Clinical Trial.
Coexistence of visceral fat and multiple risk factor accumulations is strongly associated with coronary artery disease in Japanese (the VACATION-J study).
Hiuge-Shimizu A, Kishida K, Funahashi T, Okutsu M, Kametani R, Kobayashi H, Nozaki Y, Nomura A, Yokoi H, Yoshizumi T, Ohira T, Nakamura T, Matsuzawa Y, Sumitsuji S, Shimomura I. Hiuge-Shimizu A, et al. Among authors: okutsu m. J Atheroscler Thromb. 2012;19(7):657-63. doi: 10.5551/jat.13037. Epub 2012 May 4. J Atheroscler Thromb. 2012. PMID: 22472215 Free article.
Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation.
Nakamura M, Iijima R, Ako J, Shinke T, Okada H, Ito Y, Ando K, Anzai H, Tanaka H, Ueda Y, Takiuchi S, Nishida Y, Ohira H, Kawaguchi K, Kadotani M, Niinuma H, Omiya K, Morita T, Zen K, Yasaka Y, Inoue K, Ishiwata S, Ochiai M, Hamasaki T, Yokoi H; NIPPON Investigators. Nakamura M, et al. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1189-1198. doi: 10.1016/j.jcin.2017.04.019. JACC Cardiovasc Interv. 2017. PMID: 28641838 Free article. Clinical Trial.
Predictive performance of dual modality of computed tomography angiography and intravascular ultrasound for no-reflow phenomenon after percutaneous coronary stenting in stable coronary artery disease.
Okutsu M, Horio T, Tanaka H, Akiyama M, Okimoto N, Tsubouchi T, Kawajiri K, Ohashi Y, Sumitsuji S, Ikari Y. Okutsu M, et al. Heart Vessels. 2018 Oct;33(10):1121-1128. doi: 10.1007/s00380-018-1160-2. Epub 2018 Apr 11. Heart Vessels. 2018. PMID: 29644449 Free PMC article.
Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Watanabe H, Ozasa N, Morimoto T, Shiomi H, Bingyuan B, Suwa S, Nakagawa Y, Izumi C, Kadota K, Ikeguchi S, Hibi K, Furukawa Y, Kaji S, Suzuki T, Akao M, Inada T, Hayashi Y, Nanasato M, Okutsu M, Kametani R, Sone T, Sugimura Y, Kawai K, Abe M, Kaneko H, Nakamura S, Kimura T; CAPITAL-RCT investigators. Watanabe H, et al. Among authors: okutsu m. PLoS One. 2018 Aug 28;13(8):e0199347. doi: 10.1371/journal.pone.0199347. eCollection 2018. PLoS One. 2018. PMID: 30153268 Free PMC article. Clinical Trial.
Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease.
Sakai K, Ikari Y, Nanasato M, Umetsu H, Okutsu M, Takikawa T, Sumitsuji S, Sadamatsu K, Takada M, Kato Y, Ogasawara N, Otowa K. Sakai K, et al. Among authors: okutsu m. Cardiovasc Interv Ther. 2019 Jul;34(3):234-241. doi: 10.1007/s12928-018-0552-7. Epub 2018 Oct 20. Cardiovasc Interv Ther. 2019. PMID: 30343351 Clinical Trial.
93 results